CHIMERIC VIGOR
DEAD

Serial Number

88777346

Owner

CELULARITY, INC.

Attorney

Camille M. Miller

Filing Date

Jan 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CHIMERIC VIGOR Trademark

Serial Number: 88777346

CHIMERIC VIGOR is a trademark filed by CELULARITY, INC. on January 29, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CELULARITY, INC. (50 trademarks)

33 TECHNOLOGY DRIVE
WARREN, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

January 29, 2020

Registration Date

Not Registered

Published for Opposition

June 2, 2020

Goods & Services

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, namely, for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen

Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells

Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; providing website featuring information in the field of medical research relating to banking stem cells and cord blood banking; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 28, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 28, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 30, 2022 EXRA
SOU EXTENSION 5 GRANTED
Dec 29, 2022 EX5G
SOU EXTENSION 5 FILED
Dec 27, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 27, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 29, 2022 EXRA
SOU EXTENSION 4 GRANTED
Jun 27, 2022 EX4G
SOU EXTENSION 4 FILED
Jun 27, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 27, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 1, 2022 EXRA
SOU EXTENSION 3 GRANTED
Dec 30, 2021 EX3G
SOU EXTENSION 3 FILED
Dec 30, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 30, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 28, 2021 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 8, 2021 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 16, 2021 EPPA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 29, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jun 25, 2021 EX2G
SOU EXTENSION 2 FILED
Jun 25, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 25, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 31, 2020 EXRA
SOU EXTENSION 1 GRANTED
Dec 29, 2020 EX1G
SOU EXTENSION 1 FILED
Dec 29, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 29, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 8, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 8, 2020 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 28, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 28, 2020 XAEC
ASSIGNED TO LIE
Apr 27, 2020 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 27, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 27, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 27, 2020 CNEA
ASSIGNED TO EXAMINER
Apr 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2020 NWOS
NEW APPLICATION ENTERED
Feb 1, 2020 NWAP